(Study: Frias et al., 2021) Dual Agonism: Tirzepatide's distinctive dual mechanism of action combines GLP-1 receptor activation with glucagon receptor activation, potentially resulting in even more pronounced weight loss compared to traditional GLP-1 RAs
From Receptor to Stomach: the Neural Circuit Behind the Effect Understanding how amylin reaches the stomach clarifies why cagrilintides gastric effect is both plausible and hard to guarantee
Fake doctor endorsements attempt to establish false legitimacy
Recent understandings about hypertension management in type 2 diabetes: What are the roles of SGLT2 inhibitor, GLP-1 receptor agonist, and finerenone
Geriatric Use In elderly patients, it is recommended that the dosage be limited to the smallest effective amount to preclude the development of ataxia or oversedation (2 mg to 2.5 mg once or twice daily, initially to be increased gradually as needed and tolerated)
Delivers clean, steady energy and focusno jitters, no crash